ProShare Advisors LLC Has $34.63 Million Holdings in UnitedHealth Group Incorporated (UNH)
ProShare Advisors LLC lessened its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 15.8% during the second quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 186,771 shares of the healthcare conglomerate’s stock after selling 35,104 shares during the quarter. ProShare Advisors LLC’s holdings in UnitedHealth Group were worth $34,631,000 at the end of the most recent reporting period.
Other large investors also recently made changes to their positions in the company. Meristem LLP boosted its holdings in shares of UnitedHealth Group by 1.9% during the first quarter. Meristem LLP now owns 1,785 shares of the healthcare conglomerate’s stock worth $293,000 after purchasing an additional 34 shares during the last quarter. Segment Wealth Management LLC boosted its holdings in shares of UnitedHealth Group by 6.1% during the first quarter. Segment Wealth Management LLC now owns 17,461 shares of the healthcare conglomerate’s stock worth $2,864,000 after purchasing an additional 1,002 shares during the last quarter. Buckingham Asset Management LLC boosted its holdings in shares of UnitedHealth Group by 10.3% during the first quarter. Buckingham Asset Management LLC now owns 10,334 shares of the healthcare conglomerate’s stock worth $1,695,000 after purchasing an additional 962 shares during the last quarter. Heritage Trust Co acquired a new stake in shares of UnitedHealth Group during the first quarter worth $520,000. Finally, Pitcairn Co. boosted its holdings in shares of UnitedHealth Group by 5.2% during the first quarter. Pitcairn Co. now owns 8,689 shares of the healthcare conglomerate’s stock worth $1,425,000 after purchasing an additional 428 shares during the last quarter. Hedge funds and other institutional investors own 85.71% of the company’s stock.
UnitedHealth Group Incorporated (UNH) opened at $211.22 on Friday. The company has a debt-to-equity ratio of 0.52, a current ratio of 0.70 and a quick ratio of 0.70. The firm has a market capitalization of $204,686.44, a price-to-earnings ratio of 22.00, a P/E/G ratio of 1.57 and a beta of 0.64. UnitedHealth Group Incorporated has a 52-week low of $150.00 and a 52-week high of $213.93.
UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, October 17th. The healthcare conglomerate reported $2.66 earnings per share for the quarter, topping the consensus estimate of $2.57 by $0.09. The business had revenue of $50.32 billion for the quarter, compared to analyst estimates of $50.38 billion. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.50%. The business’s quarterly revenue was up 8.7% on a year-over-year basis. During the same period last year, the company posted $2.17 EPS. analysts predict that UnitedHealth Group Incorporated will post 9.99 earnings per share for the current fiscal year.
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 12th. Shareholders of record on Friday, December 1st will be given a $0.75 dividend. This represents a $3.00 annualized dividend and a yield of 1.42%. The ex-dividend date is Thursday, November 30th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 33.26%.
In other UnitedHealth Group news, insider Larry C. Renfro sold 50,574 shares of the firm’s stock in a transaction dated Friday, September 15th. The stock was sold at an average price of $198.11, for a total value of $10,019,215.14. Following the transaction, the insider now directly owns 195,625 shares of the company’s stock, valued at $38,755,268.75. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Gail R. Wilensky sold 5,600 shares of the firm’s stock in a transaction dated Tuesday, September 5th. The shares were sold at an average price of $199.49, for a total value of $1,117,144.00. Following the completion of the transaction, the director now directly owns 60,834 shares in the company, valued at $12,135,774.66. The disclosure for this sale can be found here. Insiders sold 57,606 shares of company stock worth $11,433,133 over the last three months. 0.89% of the stock is currently owned by corporate insiders.
Several equities research analysts have recently issued reports on UNH shares. UBS AG restated an “overweight” rating on shares of UnitedHealth Group in a report on Thursday, August 24th. Zacks Investment Research cut UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Tuesday, September 26th. Morgan Stanley raised their price objective on UnitedHealth Group from $215.00 to $235.00 and gave the stock an “overweight” rating in a report on Wednesday, October 18th. ValuEngine cut UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday, October 5th. Finally, Leerink Swann restated a “buy” rating and set a $240.00 price objective (up previously from $225.00) on shares of UnitedHealth Group in a report on Wednesday, October 18th. Three analysts have rated the stock with a hold rating and twenty-four have given a buy rating to the company’s stock. The company currently has an average rating of “Buy” and a consensus price target of $216.65.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with Analyst Ratings Network's FREE daily email newsletter.